Benefit of coronary stenting using available intracoronary tools in high-risk patients. The OPTI-XIENCE study
- PMID: 40912463
- DOI: 10.1016/j.ijcard.2025.133847
Benefit of coronary stenting using available intracoronary tools in high-risk patients. The OPTI-XIENCE study
Abstract
Background: The clinical benefit of using ICT for coronary stent optimization remains uncertain in randomized trials, in which a unique ICT was used in most cases.
Aim: To assess the clinical impact of intracoronary techniques (ICT) for stent optimization in high-risk patients.
Methods: The OPTI-XIENCE study is a prospective, observational, multicenter international study including high-risk patients undergoing coronary stenting, in whom any ICT was used for stent optimization at the operator's discretion. The control group was the extended-risk cohort of the XIENCE V USA study, in which no ICT was used. The primary endpoint was the 1-year rate of target lesion failure (TLF), defined as a composite of cardiac death, target-vessel myocardial infarction, or ischemia-driven target lesion revascularization.
Results: 753 patients were included. The most frequently used ICT was optical coherence tomography (61.4 %), followed by intravascular ultrasound (22.5 %) and pressure wire in 163 (21.6 %). After propensity score matching with the XIENCE V USA cohort (n = 3179), 653 matched pairs were analyzed. The incidence of TLF at 1 year was significantly lower in the OPTI-XIENCE (3.4 % vs. 9.3 %, p < 0.001), driven by a reduction in target-vessel myocardial infarction (0.9 % vs. 5.6 %, p < 0.001) and ischemia-driven target lesion revascularization (1.1 % vs. 4.6 %, p < 0.001). The incidence of probable or definitive stent thrombosis at 1 year was 0.3 % vs 0.9 %, respectively (p = 0.154).
Conclusion: The use of any ICT for stent optimization in high-risk PCI significantly improves clinical outcomes compared to angiographic guidance alone. These findings support an individualized use of ICT to optimize complex PCI outcomes.
Keywords: Coronary physiology; Intracoronary imaging; Intravascular ultrasound; Optical coherence tomography; Percutaneous coronary intervention; Stent optimization.
Copyright © 2025 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest Conflicts of interest (Raul Moreno): I have received payments related with lecture fees and/or consultant from Abbott, Boston, Medtronic, AMGEN, AstraZeneca, Daiichi-Sankyo, Biosensors, Biotronik, Meril, Philips and Braun. All of them, not related with this manuscript. All these conflicts of interest are not related with the current manuscript.
LinkOut - more resources
Full Text Sources
Miscellaneous